Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Viral Hepatitis kills more people than HIV, malaria or tuberculosis

According to the Global Burden of Disease study released today, deaths caused by viral hepatitis have surpassed all chronic infectious diseases including HIV/AIDS, malaria and tuberculosis.

Published
18 September 2017
From
World Hepatitis Alliance
Gilead's hepatitis B therapy to vie with 20 Korean therapies

Korea has approved 20 products made by Korean companies targeting for No.1 chronic hepatitis B therapy Viread (compound: tenofovir disoproxil fumarate) made by Gilead.

Published
14 August 2017
From
Korea Biomedical Review
UK rations hepatitis B vaccine amid global shortage

Holidaymakers planning to travel abroad from the UK may not be able to get their jab in time, say experts.

Published
08 August 2017
From
BBC Health
Hepatitis B added to routine baby injections

All babies born from Tuesday in England, Wales and Northern Ireland will have an anti-hepatitis B injection added to the other routine vaccinations they are given in their early life. The jab protects against viral infections that cause cirrhosis and liver cancer.

Published
01 August 2017
From
BBC News
ECDC estimate: Around 9 million Europeans are affected by chronic hepatitis B or C

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million with chronic hepatitis C infection. But large numbers of them are not aware of their infection as they have not yet been diagnosed. On of World Hepatitis Day, ECDC Director Andrea Ammon highlights the need for Europe to scale-up coverage of testing, prevention interventions and linkage to suitable treatment services to achieve the target of eliminating viral hepatitis by 2030.

Published
27 July 2017
From
Eurekalert Inf Dis
Liver Cancer is What Killed Jailed Chinese Dissident Lu Xiaobo

The dissident’s plight has come under a global spotlight amid allegations from his supporters that Liu fell gravely ill because his cancer was not detected or treated while he was in prison. Prison authorities said Liu, who also had a history with the hepatitis B virus (HBV) received monthly check-ups and had “no abnormal conditions” before the liver cancer diagnosis.

Published
17 July 2017
From
Hepmag
Government accused of being '20 years too late' with Hepatitis B vaccinations for babies

The Government has been accused of being “20 years too late” with the introduction of a compulsory Hepatitis vaccination scheme for newborn babies for the first time this autumn. Paul Desmond, the executive director of the Hepatitis B Foundation, also told The Independent that politicians had a “psychological blindness” over its failure to test and treat migrants for the Hepatitis B virus when they arrive in the UK.

Published
10 July 2017
From
The Independent
Air Force: As many as 135 patients may have been exposed to HIV, hepatitis at Al Udeid clinic, Qatar

Improperly-cleaned medical equipment at the clinic at Al Udeid Air Base in Qatar may have exposed as many as 135 patients to blood-borne diseases such as HIV and Hepatitis B and C over an eight-year period.

Published
20 June 2017
From
Air Force Times
Graphene sensor could speed hepatitis diagnosis

Researchers in the UK and China are joining forces to develop a graphene-based sensor for on-the-spot diagnosis of hepatitis A, B and C. Particularly useful in areas with a high incidence of the highly infectious liver disease, such as China, the sensor could help stop the spread of hepatitis by speeding up diagnosis and allowing treatment to start more quickly.

Published
19 May 2017
From
The Engineer
Besifovir and tenofovir exalidex look promising as new hepatitis B drugs

Two investigational nucleotide analogue antivirals were shown to be active against hepatitis B virus (HBV) with minimal potential for kidney and bone toxicity, researchers reported at the International

Published
08 May 2017
By
Liz Highleyman
← First12345...18Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.